Supplemental Fig. 1. Gating strategy to define Treg and iNKT cell subsets. (A) Representative scatter plots showing: the lymphocyte gate (R1), CD4+ cells.

Slides:



Advertisements
Similar presentations
Supplementary Materials. Supplementary Figure S1. The effect of the freezing/thawing procedure on CD15 and CD33 marker staining on human PBMCs. Prostate.
Advertisements

Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Toll-like Receptors in Regulatory T Cells of Patients.
Suppl. Fig x106 Culture of Irradiated A-CFSE
Side Scatter Forward Scatter Lineage CD1c CD141 CD303 lineage negative
a b c Figure S1 Figure S1: Gating strategy describing T cell subsets.
Representative flow cytometry dot plots from a healthy individual
MicroRNA-21 Negatively Regulates Treg Cells Through a TGF-β1/Smad-Independent Pathway in Patients with Coronary Heart Disease Cell Physiol Biochem 2015;37:
Journal of Allergy and Clinical Immunology
A All patients Arm A Arm B Deaths/patients 21/30 7/10 14/20
PLAUhigh Tregs exhibit higher potential in suppressing effector T cells and express higher levels of Treg‐important genes, but they express lower levels.
Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis  Dao X. Nguyen, BSc, Alice Cotton, RN, BSc, Laura Attipoe, MBBS, Coziana.
by Masih Ostad, Margareta Andersson, Astrid Gruber, and Anne Sundblad
Eosinophils from Hematopoietic Stem Cell Recipients Suppress Allogeneic T Cell Proliferation  Jennie Andersson, Julia Cromvik, Madeleine Ingelsten, Christine.
Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease  Laura Cook, PhD, C. Mee.
Volume 135, Issue 6, Pages (December 2008)
CD90+ Human Dermal Stromal Cells Are Potent Inducers of FoxP3+ Regulatory T Cells  Karin Pfisterer, Karoline M. Lipnik, Erhard Hofer, Adelheid Elbe-Bürger 
Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)  Aleena.
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
A B Supplemental Figure 1 PBMC Cervical Cytobrush
Maraviroc contributes to the restoration of the homeostasis of regulatory T-cell subsets in antiretroviral-naive HIV-infected subjects  M.M. Pozo-Balado,
Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells by Ellen J. Wehrens, Gerdien.
Type 3 innate lymphoid cells induce proliferation of CD94+ natural killer cells  Shuo Li, PhD, Hideaki Morita, MD, PhD, Beate Rückert, Sci Tec, Tadech.
Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation 
Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance  Oscar Palomares, PhD,
Volume 74, Issue 6, Pages (December 2018)
Growth and Differentiation Advantages of CD4+OX40+ T Cells from Allogeneic Hematopoietic Stem Cell Transplantation Recipients  Takero Shindo, Takayuki.
Abnormalities of T-cell receptor repertoire in CD4+ regulatory and conventional T cells in patients with RAG mutations: Implications for autoimmunity 
Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets by Maria Nikolova, Jean-Daniel Lelievre, Matthieu.
Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases  Zaruhi Hovhannisyan,
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
Volume 9, Issue 3, Pages (November 2014)
Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development by Armelle Le Campion, Marie-Claude Gagnerault, Cédric.
Volume 138, Issue 3, Pages (March 2010)
Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy  Barry Moran, Cheryl M.
Volume 153, Issue 5, Pages e2 (November 2017)
A dynamic relationship between mucosal T helper type 17 and regulatory T-cell populations in nasopharynx evolves with age and associates with the clearance.
Volume 34, Issue 1, Pages (January 2011)
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Volume 85, Issue 3, Pages (March 2014)
Physical exercise modulates the homeostasis of human regulatory T cells  Max Weinhold, MA, Alexander Shimabukuro-Vornhagen, MD, Axel Franke, MD, Sebastian.
Differential expression of functional chemokine receptors on human blood and lung group 2 innate lymphoid cells  Cathryn A. Weston, PhD, Batika M.J. Rana,
Katherine G. MacDonald, BSc, Nicholas A. J
Allospecific Tregs Expanded After Anergization Remain Suppressive in Inflammatory Conditions but Lack Expression of Gut-homing Molecules  Eleni Kotsiou,
Figure S1. Representative gating of 7-hr suppression assay from one subject Teff with media alone (top row), Teff with activation beads but not Tregs (middle),
Dysregulation of proinflammatory versus anti-inflammatory human TH17 cell functionalities in the autoinflammatory Schnitzler syndrome  Rebecca Noster,
Increased, but Functionally Impaired, CD14+ HLA-DR–/low Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T Cells  David C. Soler,
A Two-Step Process for Thymic Regulatory T Cell Development
Volume 28, Issue 6, Pages (June 2008)
Brent E. Palmer, PhD, Douglas G. Mack, PhD, Allison K
Bet v 1–specific T-cell receptor/forkhead box protein 3 transgenic T cells suppress Bet v 1–specific T-cell effector function in an activation-dependent.
Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells  Matthieu Allez, Jens Brimnes, Iris Dotan, Lloyd.
Volume 30, Issue 6, Pages (June 2009)
Molecular Therapy - Methods & Clinical Development
Fig. 1 Effect of preinfection β7Hi CD45RA−CD4+ T cell frequency on HIV acquisition risk in CAPRISA 004 study. Effect of preinfection β7Hi CD45RA−CD4+ T.
Volume 32, Issue 1, Pages (January 2010)
CD127low/- and FoxP3+ Expression Levels Characterize Different Regulatory T-Cell Populations in Human Peripheral Blood  Sandra Klein, Cosima C. Kretz,
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease by Jennifer S. Whangbo, Haesook.
Volume 46, Issue 4, Pages (April 2017)
Differential expression of TRM markers by donor- and recipient-derived T cells with time. Differential expression of TRM markers by donor- and recipient-derived.
Machteld M. Tiemessen, Tracey J. Mitchell, Lisa Hendry, Sean J
Blood Tfr cells do not show specialized humoral regulatory capacity.
GIFT15 Bregs ameliorate EAE and induce in vivo formation of CD25+FoxP3+ Tregs and CD49b+CD223+ Tr1s in mice with EAE. A, The evolution of clinical score.
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 36, Issue 5, Pages (May 2012)
Canonical but not adaptive NK-cell function is suppressed by Tregs.
Patient Tregs express normal levels of suppression.
Intratumoral changes in critical lymphocyte populations and numbers after NKTR-214 treatment. Intratumoral changes in critical lymphocyte populations and.
Flow cytometric gating strategy used to identify CD69 surface expression on CD4 (left paired columns) and CD8 (right paired columns) T lymphocytes. Flow.
IL35 regulation of tumor growth is accompanied by suppression of CD4+ effector T-cell activity and expansion of Tregs. IL35 regulation of tumor growth.
A Key Role of Leptin in the Control of Regulatory T Cell Proliferation
Presentation transcript:

Supplemental Fig. 1. Gating strategy to define Treg and iNKT cell subsets. (A) Representative scatter plots showing: the lymphocyte gate (R1), CD4+ cells (R2), CD4+ cells with CD25 and FoxP3 co-expression (R3). The boxed areas for Foxp3 were gated on the top part of the near linear correlation with CD25, as it represent the cells with higher CD25 expression and stronger suppressive capacity. (B) CD3+ cells expressing Vα24 and Vβ11 TCR chains (R3) in cells acquired from one mL of blood.

Supplemental Fig. 2. Representative suppression assay. (A) Stimulated PBMCs were cultured alone (ratio Treg:responder of 0:1) or with Treg at various ratios (1:1, 1:2 and 1:4). CFSE dilution graphs from a representative assay showed Treg suppressive capacity up to 1:4 ratio. The corresponding Proliferation index (PI) was calculated using the ModFit LT for Win32 software. (B) Suppression assay with co-culture with Treg or non-labelled PBMC. Representative data on graphs are presented as the mean± SEM.

Supplemental Fig. 3. Correlation between frequency of peripheral Treg and free thyroxine level in Graves’ disease patients before RAI therapy. Each data of the proportion of CD4 + CD25 hi FoxP3 + Treg cells over the total peripheral CD4 + T cells is paired with the same patient’s free thyroxine value (F T4) in G patients (n = 26) sorting out those taking antithyroid medication (black circle, G- ATD, n = 11) or not (white circle, G-no ATD, n = 15) ns: not significant.

Supplemental Fig. 4. Proportion variation in frequency of peripheral Treg before and after radioiodine therapy in patients with Graves’ disease. Each data of the proportion variation of CD4 + CD25 hi FoxP3 + Treg cells over the total peripheral CD4 + T cells in 5 patients with hypothyroidism after RAI therapy (Low T4) and in 10 patients without hypothyrodism (Normal/High T4) are shown. All data are presented as the variation of the proportion using the formula: [Number of cells from (Sample post RAI/Sample pre RAI)]-1, and presented on graphs as the mean ± SD. ns: not significant.